Physician
Orthopaedic Surgery
Dr. Paul B. Canale, MD
|
|
Give Review
Paul Canale practices Orthopaedic Surgery. He graduated from Wayne State University School of Medicine. Wayne State University School of Medicine is ranked 63/85 in Research/PrimaryCare. Paul Canale is also published. He has 29 publications published. The lastest publication: "Leukocyte integrin very late antigen-4/vascular cell adhesion molecule-1 adhesion pathway in splanchnic artery occlusion shock.' He is registered with Medicare and accepts Medicare payments.
Publications
- Evidence for a role of platelet activating factor in hypovolemic shock in the rat.
- Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock.
- TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock.
- Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
- Contribution of intercellular adhesion molecule 1 (ICAM-1) to the pathogenesis of splanchnic artery occlusion shock in the rat.
- Antibodies against intercellular adhesion molecule 1 protect against myocardial ischaemia-reperfusion injury in rat.
- Protective effects of BAY U 3405, a thromboxane A2 receptor antagonist, in endotoxin shock.
- Improved survival and reversal of endothelial dysfunction by the 21-aminosteroid, U-74389G in splanchnic ischaemia-reperfusion injury in the rat.
- Tumor necrosis factor induces E-selectin production in splanchnic artery occlusion shock.
- E-selectin involvement in the pathogenesis of splanchnic artery occlusion shock.
- E-selectin in the pathogenesis of experimental myocardial ischemia-reperfusion injury.
- Protective effects of L-659,989, a platelet-activating factor receptor antagonist, in myocardial ischemia and reperfusion in rats.
- Tumour necrosis factor mediates E-selectin production and leukocyte accumulation in myocardial ischaemia-reperfusion injury.
- Leukocyte integrin very late antigen-4/vascular cell adhesion molecule-1 adhesion pathway in splanchnic artery occlusion shock.
- Effects of cloricromene on the levels of endothelin and on the microcirculatory function in peripheral atherosclerotic arteriopathies.
- Endotoxin tolerance impairs a pertussis-toxin-sensitive G-protein regulating tumour necrosis factor release by macrophages from tumour-bearing rats.
- Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock.
- Effects of S-ethylisothiourea, a potent inhibitor of nitric oxide synthase, alone or in combination with a nitric oxide donor in splanchnic artery occlusion shock.
- Thrombolytic therapy with urokinase reduces increased circulating endothelial adhesion molecules in acute myocardial infarction.
- Soluble E-selectin levels in acute human myocardial infarction.
- Protection of ischemic and reperfused rat myocardium by the nonglucocorticoid 21-aminosteroid U-74389G, a new inhibitor of lipid peroxidation.
- G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-alpha biosynthesis.
- Splanchnic artery occlusion shock: vinblastine-induced leukopenia reduces tumour necrosis factor and thromboxane A2 formation, and increases survival rate.
- G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, reduces myocardial damage and polymorphonuclear leukocyte accumulation following co...
- Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial i...
- Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injury.
- The Mitchell procedure for the treatment of adolescent hallux valgus. A long-term study.
- Interdigital (Morton) neuroma: high-resolution MR imaging with a solenoid coil.
Schools
Rosalind Franklin University of Medicine and Science Chicago Medical School
Procedures Preformed
- Carpal Tunnel Release
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- Dural Repair or Other Spinal Spinal Cord Repair
- Elbow Fracture and-or Dislocation Treatment, Open
- View All
Conditions Treated
- Achilles Tendinitis
- Adhesive Capsulitis
- Ankle Fracture
- Ankle Sprain and Achilles Tendon Sprain or Rupture
- View All
Doctors Specialties
- Orthopedic Surgery
- Orthopaedic Surgery
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Dental Blue 100/200/300
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- First Health (Coventry Health Care) PPO
- Golden Rule
- GEHA
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- United Healthcare
Education
-
Medical College of Wisconsin Affiliated Hospitals -
Wayne State University School of Medicine -
Rosalind Franklin University of Medicine and Science
Drug Facts
| NPI NUMBER | 1710973490 | |
| NPPES Provider LastName | CANALE | |
| NPPES Provider FirstName | PAUL | |
| NPPES Provider ZIPCode | 365264298 | |
| NPPES Provider State | AL | |
| Specialty Description | Orthopedic Surgery | |
| Total Claim Count | 901.0 | |
| Distinct Opioid Count | 8.0 | |
| Opioid Claim Count | 504.0 | |
| Percent Opioid Claims | 55.94 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1710973490 |
| Last Name Of The Provider | CANALE |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
Dr. Daniel E. Matthews, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Earl R. Hubley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John L. Todd, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank B. Fondren III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George A. Corbett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew W. Goldman, MD
This Doctor is OpenDoctor Recommended.
|